Related Experiment Video

Updated: Feb 5, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K

CHLOROQUINE DOES NOT CANCEL E1A+cHa-Ras TRANSFORMANTS’ DEATH INDUCED BY mTOR KINASE INHIBITOR pp242

T V Bykova, S G Zubova, E Yu Kochetkova

    Tsitologiia
    |September 7, 2018
    PubMed

    Insights

    Combining chloroquine and pp242 effectively induces cell death in Ras-transformed cells. This approach targets both intact and senescent cells by inhibiting autophagy and mitochondrial function.

    Area of Science:

    • Cell Biology
    • Biochemistry
    • Oncology

    Background:

    • Cellular senescence and autophagy are critical processes in aging and cancer.
    • Ras-transformed cells exhibit altered metabolic and survival pathways.
    • Understanding the interplay between autophagy and cell death is crucial for therapeutic development.

    Purpose of the Study:

    • To investigate the impact of TORC1/C2 kinase inhibitor pp242 on cell viability and autophagy in control and senescent Ras-transformed rat embryo fibroblasts.
    • To evaluate the efficacy of combining pp242 with chloroquine, a lysosome inhibitor, in inducing cell death.

    Main Methods:

    • Induction of cell senescence using sodium butyrate.
    • Treatment of fibroblasts with pp242 to trigger autophagy.
    • Assessment of mitochondrial activity and cell death pathways (mitophagy, apoptosis).
    • Combination treatment with pp242 and chloroquine.

    Main Results:

    • pp242 significantly reduced mitochondrial activity and induced cell death via mitophagy and apoptosis in intact cells.
    • Senescent cells showed greater resistance to pp242 compared to control cells.
    • The combination of chloroquine and pp242 markedly reduced the viability of both intact and senescent Ras-transformed cells.
    • Chloroquine did not abolish the effects of pp242, suggesting a complex interplay.

    Conclusions:

    • The combination of chloroquine and pp242 is a promising strategy for inducing cell death in Ras-transformed cells.
    • This combined approach effectively targets both non-senescent and senescent transformed cells.
    • Further research into this combination therapy could offer new avenues for cancer treatment.

    More Related Videos

    Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

    Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

    Published on: September 19, 2018

    8.4K
    Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

    Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

    Published on: October 23, 2019

    8.3K

    Related Concept Videos

    The Ras Gene02:38

    The Ras Gene

    The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
    Ras is a...
    7.3K
    Protein Kinases and Phosphatases02:54

    Protein Kinases and Phosphatases

    Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
    Protein kinases
    Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
    15.2K
    Small GTPases - Ras and Rho01:24

    Small GTPases - Ras and Rho

    Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
    Three regulatory proteins control their activity:
    5.4K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    4.8K
    Bacterial Transformation01:33

    Bacterial Transformation

    In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
    Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
    60.1K
    Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

    Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

    Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
    TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
    544